Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Virus Adaptation and Selection Following Challenge of Animals Vaccinated against Classical Swine Fever Virus

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Protoparvovirus Cell Entry

    Publikation: Bidrag til tidsskriftReviewpeer review

  3. Mechanisms and factors that influence high frequency retroviral recombination

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

We report the in vitro efficacy of ion-channel inhibitors amantadine, memantine and rimantadine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In VeroE6 cells, rimantadine was most potent followed by memantine and amantadine (50% effective concentrations: 36, 80 and 116 µM, respectively). Rimantadine also showed the highest selectivity index, followed by amantadine and memantine (17.3, 12.2 and 7.6, respectively). Similar results were observed in human hepatoma Huh7.5 and lung carcinoma A549-hACE2 cells. Inhibitors interacted in a similar antagonistic manner with remdesivir and had a similar barrier to viral escape. Rimantadine acted mainly at the viral post-entry level and partially at the viral entry level. Based on these results, rimantadine showed the most promise for treatment of SARS-CoV-2.

OriginalsprogEngelsk
Artikelnummer2082
TidsskriftViruses
Vol/bind13
Udgave nummer10
ISSN1999-4915
DOI
StatusUdgivet - 15 okt. 2021

ID: 68561622